Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Antibiotic Susceptibility-based Tailored Versus Empiric Therapy for Helicobacter Pylori First-line Treatment：a Randomized Clinical Trial

NCT02935010 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT02935010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Antibiotic Susceptibility-based Tailored Versus Empiric Therapy for Helicobacter Pylori First-line Treatment：a Randomized Clinical Trial
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
February 5, 2017
Completion date
March 31, 2018
Enrollment
382 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection